Research Blog
Evidence-based articles on peptide mechanisms, dosing protocols, clinical data, and research methodology. Cited sources. No hype.
IGF-1 vs IGF-1 LR3: Why the Modified Version Lasts Twelve Times Longer
IGF-1 LR3 was engineered to escape the binding proteins that suppress native IGF-1 in serum. The modification is a 13-residue extension and an arginine substitution. Here is what those two changes do and why the cell-culture and in vivo data look different than they do for the native peptide.
Kisspeptin-10: The Peptide That Started Puberty in Mice With No Receptor
In 2003 two groups simultaneously showed that loss of the GPR54 receptor blocked puberty in mice and humans. The endogenous ligand turned out to be kisspeptin. Twenty years later it is one of the most studied peptides in reproductive neuroendocrinology.
NAD+, NMN, NR: What's Actually Different When You Pick a Precursor
All three names show up on supplement bottles and in research papers, often interchangeably. They are not interchangeable. Here is what the bioavailability and tissue distribution data say about which one ends up where.
BPC-157 and the Gut: What the Pliva Croatian Trials Actually Tested
Before BPC-157 became a peptide-research mainstay, it spent two decades in pharmaceutical development as PLD-116 and PL 14736 — a candidate inflammatory bowel disease drug. The Phase II data is real and rarely cited correctly.
Thymosin Beta-4 and the Actin Pool: What TB-500 Actually Does at the Cellular Level
TB-500 is a fragment of thymosin beta-4, a 43-residue protein whose primary cellular role is sequestering G-actin monomers. The mechanism is unusual, the literature is dense, and the therapeutic implications are still being worked out.
Semax: The ACTH Fragment That Russian Pharmacology Built a Cognitive Drug Around
Semax is approved as a cognitive drug in Russia. It is a 7-amino-acid fragment of ACTH(4-10) with a small modification, and the published research on its BDNF and dopaminergic effects spans three decades and two languages.
PT-141 / Bremelanotide: From the Tan-Sex Sunscreen to FDA Approval and Back
PT-141 has one of the more unusual development histories in peptide pharmacology. It started as a melanocortin tanning agent, became a sexual function drug after researchers noticed an unexpected side effect, got FDA-approved as Vyleesi in 2019, and continues as a research tool for melanocortin receptor pharmacology.
Why BPC-157, TB-500, and GHK-Cu Get Stacked Together: The Mechanism Map
Three peptides, three different cellular processes, one tissue-repair logic. The combination has become one of the most-used research stacks. Here is the mechanistic case for why — and what the evidence actually supports.
How to Reconstitute Peptides: Step-by-Step Lab Protocol
Lyophilized peptides arrive as dry powder or cake. Research-chemical reconstitution requires the right solvent, the slow-stream technique, and concentration math to keep a research solution intact.
Bacteriostatic Water for Peptides: Sourcing and Sterility
Bacteriostatic water is sterile water plus 0.9% benzyl alcohol. That additive makes it safe for multi-dose lab use. Here is what it is, where U.S. labs source it, and how storage affects it.
Are Research Peptides Legal in the U.S.? RUO and FDA
Research peptides occupy a defined but frequently misunderstood legal category in the U.S. The answer depends on which law applies, what the peptide is, who is buying it, and what it is labeled for.
Peptides Near Me: Where Research Labs Source Peptides in Major U.S. Metros
When a lab technician types 'peptides near me,' they are almost certainly asking the wrong question. Here is how research institutions across the ten largest U.S. metros actually source RUO peptides — and why geography matters less than cold-chain logistics.
Polypeptide vs Peptide vs Protein: Definitions, Sizes, and Why It Matters
The terms peptide, polypeptide, and protein are used interchangeably in casual conversation and inconsistently in the primary literature. The distinctions are real, biologically meaningful, and directly relevant to how researchers synthesize, store, and handle these molecules in the lab.
BPC-157 vs. TB-500: What the Research Actually Shows About Each Peptide
BPC-157 and TB-500 are frequently compared and often stacked — but their mechanisms are genuinely distinct. A research-grounded breakdown of what the published data actually shows for each peptide.
CJC-1295 With vs. Without DAC: Pharmacokinetics, Half-Life, and What Matters for Research
CJC-1295 with DAC has a half-life of 5.8–8.1 days; the no-DAC version clears in 20–30 minutes. A data-grounded breakdown of what those numbers mean for GH pulsatility and research protocol design.
How to Evaluate Peptide Purity: HPLC Reports, Mass Spec, and Red Flags to Watch For
Reading a peptide certificate of analysis competently requires understanding what HPLC purity actually measures, what mass spec confirms, and what missing data should make you walk away.
The CJC-1295 + Ipamorelin Stack: Research Rationale and Synergy Data
CJC-1295 and Ipamorelin target different receptor systems — GHRH receptors and GHS-R1a respectively — creating synergistic GH pulses that exceed either compound alone. A mechanistic breakdown of why the combination works.
Peptide Reconstitution and Handling: A Researcher's Guide to Not Ruining Expensive Compounds
Peptide reconstitution done wrong can degrade a significant fraction of your compound before any experiment starts. A practical guide covering the chemistry, math, and technique that protect expensive research peptides.
Research Peptide Dosing Protocols: What Published Studies Actually Used
A breakdown of the actual doses used in published BPC-157, CJC-1295, ipamorelin, AOD-9604, and Epithalon research — with a clear explanation of how allometric scaling converts animal study data to human equivalent doses.
Healing Peptide Blends: BPC-157 + TB-500 + GHK-Cu — Why Researchers Combine Them
BPC-157, TB-500, and GHK-Cu each target different phases of the tissue repair cascade. A research-based explanation of the three-phase healing model and why the published data supports studying these peptides together.
How BPC-157 Actually Works: The Nitric Oxide, VEGF, and Growth Factor Story
A mechanistic deep dive into how BPC-157 works: nitric oxide modulation via Src-Cav-1-eNOS, VEGFR2-driven angiogenesis, FAK-paxillin cell migration activation, and the gut-brain axis connection from published research.
Epithalon and Telomere Research: What Khavinson's Studies Actually Found
What Khavinson's telomerase findings, the Anisimov lifespan study, and recent cell line research actually found — including an honest account of the evidence's limitations and what remains to be established.
MOTS-c: The Mitochondrial Peptide That Acts Like an Exercise Pill
MOTS-c is a mitochondrial-encoded peptide that rises during exercise and activates AMPK — doubling running capacity in old mice in USC's Reynolds 2021 study. A detailed look at what the research actually found.
Thymosin Alpha-1 and Immune Modulation: From Hepatitis Treatment to Broader Applications
Thymosin alpha-1 is approved in over 35 countries for hepatitis treatment and carries one of the most extensive clinical records of any research peptide — including compelling COVID-19 mortality data from 2020. Here's what the research actually shows about its Toll-like receptor mechanism and who benefits most.
AOD 9604 Research: What 900 Clinical Trial Participants Taught Us About This GH Fragment
AOD 9604 went through multiple human clinical trials enrolling 900+ participants before Metabolic Pharmaceuticals discontinued it in 2007. The story of what those trials found — and why the compound failed commercially despite real efficacy signals — is one of the most instructive in peptide research.
PT-141 (Bremelanotide): From NASA Sunscreen Accident to FDA-Approved Sexual Health Peptide
PT-141 (bremelanotide) began with an accidental self-injection at the University of Arizona and ended as FDA-approved Vyleesi. The research history spanning Melanotan II's discovery through the RECONNECT Phase 3 trials illuminates the melanocortin-4 receptor mechanism underlying sexual desire.
Semax: The Russian Nootropic Peptide That Western Science Is Finally Noticing
Semax has been clinically approved in Russia for over 30 years for stroke and cognitive disorders, yet remains largely unknown in Western research circles. The compound's BDNF-upregulating mechanism, genome-wide ischemia transcriptome data, and three decades of clinical use make it one of the most substantively researched nootropic peptides available.
Peptides 101: What They Are, How They Differ From Proteins, and Why Researchers Care
Peptides are short chains of amino acids, but that simple definition conceals a world of complexity that determines how they're made, how they work, and why researchers find them more interesting than ever. This guide covers the fundamentals — structure, synthesis, purity, and the major research categories — for anyone starting to explore the field.
The Science of Recovery: How Your Body Heals Tendons, Ligaments, and Muscle — And What Peptides May Add
Tendons and ligaments heal slowly — and often incompletely. Here's the biology behind why, and what the research on BPC-157, TB-500, and GHK-Cu says about where peptides might fit in the recovery process.
Growth Hormone Secretagogues Explained: The Researcher's Guide to GHRH and GHRP Peptides
GHRH analogs like CJC-1295 and ghrelin mimetics like Ipamorelin work through distinct pathways to stimulate the body's own GH production — a fundamentally different approach from exogenous growth hormone. Here's the endocrinology behind how they work.
Longevity Peptides: What Does the Research Say About NAD+, Epithalon, and Glutathione?
NAD+ depletion, telomere shortening, and oxidative stress are three of the most studied mechanisms in aging biology. Here's what the research on Epithalon, NAD+, Glutathione, and MOTS-c actually shows — and what it doesn't yet tell us.
Sleep, Circadian Rhythm, and Peptides: DSIP and the Neuroscience of Deep Rest
DSIP — delta sleep-inducing peptide — was isolated from rabbits in 1977 and doesn't work like any sedative. It selectively promotes deep-wave sleep patterns and may be part of the endogenous mechanism behind sleep-related growth hormone secretion. Here's the research.
Biohacking and Peptide Research: How the Consumer Science Community Is Driving Discovery
The biohacker and citizen science community isn't waiting for clinical trials. Here's how consumer demand is reshaping peptide research priorities — and why quality sourcing matters more than most people in this space realize.